REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Biomapas (Lithuania)

Main Activities: Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: UAB Biomapas Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Biomapas is an enterprise based in Lithuania. Its main office is in Kaunas. It operates in the Scientific Research and Development Services industry. It was incorporated on April 09, 2001. There are currently 92 (2025) people employed by UAB Biomapas. In its most recent financial highlights, the company reported a net sales revenue increase of 8.78% in 2024. UAB Biomapas’s net profit margin decreased by 3.76% in 2024.

Headquarters
K. Donelaicio g. 60
Kaunas; Kaunas County; Postal Code: LT-44248

Contact Details: Purchase the UAB Biomapas report to view the information.

Basic Information
Total Employees:
Purchase the UAB Biomapas report to view the information.
Registered Capital:
Purchase the UAB Biomapas report to view the information.
Financial Auditors:
Purchase the UAB Biomapas report to view the information.
Incorporation Date:
April 09, 2001
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Company Performance
Financial values in the chart are available after UAB Biomapas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
8.78%
Total Operating Revenue
8.78%
Net Profit/Loss for the Period
-25.2%
Total Equity
-3.24%
Net Profit Margin
-3.76%
Return on Equity (ROE)
-13.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?